UpcomingPDUFA target action date

Bezuclastinib

Cogent Biosciences (COGT)

Marketer take

The company says it is preparing to launch in GIST, a disease treated by a small group of sarcoma-focused oncologists, so competing GIST brands should expect concentrated, sequencing-focused messaging at the same centers.

Sponsor company
Cogent Biosciences (COGT)
Indication
Gastrointestinal stromal tumor (GIST)
Therapeutic area
Oncology
Event
PDUFA target action date
Date
Nov 30, 2026
Status
Upcoming
Source
company press release
Last verified
Nov 15, 2026

Dates and status come from the linked public source as of the last verified date. Spot an error or have an update?

Get alerts when FDA dates move